Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
---|---|---|---|---|---|---|---|
Aug 05, 2015 | Director | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 5,795 | $15.81 | 53,730 | |
Aug 05, 2015 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | -- | -- | |
Aug 05, 2015 | SVP and General Counsel | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,800 | $15.27 | 49,128 | |
Aug 05, 2015 | SVP and General Counsel | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 5,674 | $15.81 | 43,454 | |
Aug 05, 2015 | SVP and General Counsel | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,800 | -- | -- | |
Aug 03, 2015 | President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 2,014 | $15.54 | 202,431 | |
Aug 03, 2015 | VP - Global Franchise | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 633 | $15.54 | 23,137 | |
Aug 03, 2015 | VP - Global Franchise | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 561 | $15.54 | 24,576 | |
Aug 03, 2015 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 893 | $15.54 | 31,764 | |
Aug 03, 2015 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 759 | $15.54 | 31,005 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.